骨质疏松症治疗的研究进展  

Research Progress in Treatment of Osteoporosis

在线阅读下载全文

作  者:谈荣珍 胡梁深 杨盼盼 胡俊[1] 张斌[1] 肖茜琼 袁忠[1] TAN Rongzhen;HU Liangshen;YANG Panpan;HU Jun;ZHANG Bin;XIAO Xiqiong;YUAN Zhong(Department of Osteoporosis,Nanchang Hongdu Hospital of Traditional Chinese Medicine,Nanchang 330006,China;Department of Sports Medicine,Nanchang Hongdu Hospital of Traditional Chinese Medicine,Nanchang 330006,China)

机构地区:[1]南昌市洪都中医院骨质疏松科,南昌330006 [2]南昌市洪都中医院运动医学科,南昌330006

出  处:《医学综述》2024年第11期1319-1323,1328,共6页Medical Recapitulate

基  金:江西省卫生健康委科技计划项目(202140160,202140170);江西省中医药管理局科技计划项目(2023B0687,2021A188)。

摘  要:骨质疏松症(OP)是一种常见的发病率高的骨病,对我国居民的健康造成严重影响,给社会带来沉重的负担。因此,研究其治疗方法尤为重要。目前,OP的西医治疗方法以药物和非药物疗法为主,其中药物治疗包括骨吸收抑制剂、骨形成促进剂及双重作用药物,非药物治疗包括运动治疗、物理因子治疗等。而中医则采用中药、中医特色治疗等,常见中药方为补肾填精、补气养血、健脾益肾方等,中医特色治疗包括针刺治疗、灸法治疗、穴位贴敷、功法、食疗等。未来可对OP的治疗方法进行深入探索,以期为临床实践提供帮助。Osteoporosis(OP)is a common bone disease with a high incidence,which has a serious impact on the health of our residents and adds a heavy burden on the society in China.Therefore,it is particularly important to study its treatment method.At present,the western medicine treatment methods for OP are mainly drug and non-drug therapies,among which drug therapy includes bone resorption inhibitors,bone formation promoters,and dual acting drugs,and non-drug therapy includes exercise therapy,physical factor therapy,etc.Traditional Chinese medicine(TCM)adopts Chinese herbals and its unique treatments.Common TCM prescriptions are formula for tonifying kidney and filling essence,tonifying qi and nourishing blood,and nourishing spleen and kidney.TCM unique treatments include acupuncture,moxibustion,acupoint application,exercises,diet therapy,etc.In the future,in-depth exploration of treatment methods for OP can be conducted to provide assistance for the clinical practice.

关 键 词:骨质疏松症 中医治疗 西医治疗 骨吸收 骨形成 

分 类 号:R681[医药卫生—骨科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象